Cancer Genetics enters supply agreement with Agilent Technologies
Cancer Genetics announced it has signed a non-exclusive supply agreement with Agilent Technologies through which Agilent will manufacture Cancer Genetics’ proprietary FISH probe reagents. September 25, 2018